Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device

Daniel B. Sims, Gregg Rosner, Nir Uriel, José González-Costello, Frederick A. Ehlert, Ulrich P. Jorde

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)

Original languageEnglish (US)
Pages (from-to)e144-e148
JournalPACE - Pacing and Clinical Electrophysiology
Volume35
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

Keywords

  • chronic heart failure
  • left ventricular assist device
  • ventricular fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device'. Together they form a unique fingerprint.

Cite this